Author Topic: Researchers uncover potential risks of beta-interferon treatment for MS  (Read 114 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9821
  • MS diagnosed 1980
  • Location: Pacific Northwest
A University of British Columbia study has revealed increased risks for stroke, migraine, depression and blood abnormalities in people with MS taking beta-interferons:

Quote
The study aimed to identify potential adverse events related to beta-interferon treatment for relapsing-remitting multiple sclerosis by analyzing health records of over 2,000 British Columbians with multiple sclerosis between 1995 and 2008.

The article, "Researchers uncover potential risks of common MS treatment," in Medical News Today (May 17) is available here:



http://www.medicalnewstoday.com/releases/317492.php
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
256 Views
Last post July 25, 2017, 08:57:52 pm
by agate
0 Replies
213 Views
Last post July 25, 2017, 09:03:33 pm
by agate
0 Replies
81 Views
Last post March 07, 2018, 03:58:01 pm
by agate
0 Replies
107 Views
Last post December 29, 2018, 04:21:30 pm
by agate
0 Replies
35 Views
Last post December 21, 2021, 06:20:24 am
by agate